Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways

Food and Chemical Toxicology

Volumn 66, Issue , 2014, Pages 7-13

  Xia, Juan ^a   Guo, Shiwei ^b   Fang, Tao ^a   Feng, Du ^a   Zhang, Xingli ^a   Zhang, Qingyu ^a   Liu, Jie ^a   Liu, Bin ^a   Li, Mingyi ^a   Zhu, Runzhi ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; DHM; MTOR; Tumor

Indexed keywords

DIHYDROMYRICETIN; FLAVONOL DERIVATIVE; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ANTAGONISTS AND INHIBITORS; AUTOPHAGY; CELL PROLIFERATION; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; TRANSMISSION ELECTRON MICROSCOPY;

AUTOPHAGY; CELL PROLIFERATION; FLAVONOLS; HEP G2 CELLS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHORYLATION; TOR SERINE-THREONINE KINASES;

EID: 84893477310     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.014     Document Type: Article

References (46)

1. Amaravadi R.K., Lippincott-Schwartz J., Yin X.-M., Weiss W.A., Takebe N., Timmer W., DiPaola R.S., Lotze M.T., White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
2. Blackman, G., 2013. Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication. US Patent 20,130,017,276.
3. Blagosklonny M.V. Hypoxia, MTOR and autophagy: converging on senescence or quiescence. Autophagy 2013, 9:260-262.
4. Capparelli C., Guido C., Whitaker-Menezes D., Bonuccelli G., Balliet R., Pestell T.G., Goldberg A.F., Pestell R.G., Howell A., Sneddon S. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 2012, 11:2285-2302.
5. Chang Y., Li Y., Hu J., Guo J., Xu D., Xie H., Lv X., Shi T., Chen Y. Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo. Cancer Lett. 2012.
6. Chen N., Debnath J. Autophagy and tumorigenesis. FEBS Lett. 2010, 584:1427-1435.
7. Chen N., Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol. Ther. 2011, 11:157-168.
8. Chen T., Hao J., He J., Zhang J., Li Y., Liu R., Li L. Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cells. Food Chem. 2012.
9. Degtyarev M., De Mazière A., Orr C., Lin J., Lee B.B., Tien J.Y., Prior W.W., van Dijk S., Wu H., Gray D.C. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J. Cell Biol. 2008, 183:101-116.
10. Ding Z.-B., Hui B., Shi Y.-H., Zhou J., Peng Y.-F., Gu C.-Y., Yang H., Shi G.-M., Ke A.-W., Wang X.-Y. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin. Cancer Res. 2011, 17:6229-6238.
11. Feng Z., Zhang H., Levine A.J., Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. USA 2005, 102:8204-8209.
12. Fulda S., Gorman A.M., Hori O., Samali A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010.
13. Gao Q., Yang X., Ou M. Effect of serum containing tengcha total flavonoid and dihydromyricetin on proliferation and apoptosis of HepG2 cells]. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China J. Chin. Mater. Med. 2011, 36:500.
14. Hanahan D., Weinberg R.A. Hallmarks of cancer. Cell 2000, 100:57-70.
15. Hippert M.M., O'Toole P.S., Thorburn A. Autophagy in cancer: good, bad, or both?. Cancer Res. 2006, 66:9349-9351.
16. Hu C., Zou M.-J., Zhao L., Lu N., Sun Y.-J., Gou S.-H., Xi T., Guo Q.-L. E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells. Toxicol. Lett. 2012, 210:78-86.
17. Janku F., McConkey D.J., Hong D.S., Kurzrock R. Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 2011, 8:528-539.
18. Jung C.H., Ro S.-H., Cao J., Otto N.M., Kim D.-H. MTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
19. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
20. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117:2805-2812.
21. Kim J., Guan K.-L. Amino acid signaling in TOR activation. Ann. Rev. Biochem. 2011, 80:1001-1032.
22. Kondo Y., Kondo S. Autophagy and cancer therapy. Autophagy 2006, 2:85-90.
23. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
24. Kuma A., Matsui M., Mizushima N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 2007, 3:323-328.
25. Laplante M., Sabatini D.M. MTOR signaling in growth control and disease. Cell 2012, 149:274-293.
26. Li M., Jiang X., Liu D., Na Y., Gao G.F., Xi Z. Autophagy protects LNCaP cells under androgen deprivation conditions. Autophagy 2008, 4:54-60.
27. Li, H., Bai, L., Hu, Y., 2011. Chemical synthesis and bioactive research of dihydromyricetin-manganese complex. In: Remote Sensing, Environment and Transportation Engineering (RSETE), 2011 International Conference on. IEEE, pp. 7438-7441.
28. Liu B., Du J., Zeng J., Chen C., Niu S. Characterization and antioxidant activity of dihydromyricetin-lecithin complex. Eur. Food Res. Technol. 2009, 230:325-331.
29. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Montalto G., Cervello M., Nicoletti F., Fagone P., Malaponte G., Mazzarino M.C. Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget 2012, 3:954-987.
30. Mizushima N. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 2004, 36:2491-2502.
31. Neufeld T.P. TOR-dependent control of autophagy: biting the hand that feeds. Curr. Opin. Cell Biol. 2010, 22:157-168.
32. Pang R., Tao J.-Y., Zhang S.-L., Chen K.-L., Zhao L., Yue X., Wang Y.-F., Ye P., Zhu Y., Wu J.-G. Ethanol extract from Ampelopsis sinica root exerts anti-hepatitis B virus activity via inhibition of p53 pathway in vitro. Evid.-Based Complement. Alternative Med. 2011.
33. Panwalkar A., Verstovsek S., Giles F.J. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer 2004, 100:657-666.
34. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
35. Pavlides S., Vera I., Gandara R., Sneddon S., Pestell R.G., Mercier I., Martinez-Outschoorn U.E., Whitaker-Menezes D., Howell A., Sotgia F. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxidants Redox Signal. 2012, 16:1264-1284.
36. Saiki S., Sasazawa Y., Imamichi Y., Kawajiri S., Fujimaki T., Tanida I., Kobayashi H., Sato F., Sato S., Ishikawa K.-I. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 2011, 7:176-187.
37. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 2005, 17:596-603.
38. Sugiyama M., Takahashi H., Hosono K., Endo H., Kato S., Yoneda K., Nozaki Y., Fujita K., Yoneda M., Wada K. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int. J. Oncol. 2009, 34:339-344.
39. Wang Y., Qiu Q., Shen J.-J., Li D.-D., Jiang X.-J., Si S.-Y., Shao R.-G., Wang Z. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. Int. J. Biochem. Cell Biol. 2012.
40. Wu Y.-T., Tan H.-L., Huang Q., Ong C.-N., Shen H.-M. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy 2009, 5:824-834.
41. Wu S., Liu B., Zhang Q., Liu J., Zhou W., Wang C., Li M., Bao S., Zhu R. Dihydromyricetin reduced Bcl-2 expression via p53 in Human Hepatoma HepG2 Cells. PloS one 2013, 8:e76886.
42. Xie C.-M., Chan W.Y., Yu S., Zhao J., Cheng C.H. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Rad. Biol. Med. 2011, 51:1365-1375.
43. Xie X., White E.P., Mehnert J.M. Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PloS one 2013, 8:e55096.
44. Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22:124-131.
45. Yang J., Benguo L., Liu F., Zhang Y. Apoptosis induced by the inclusion complex of dihydromyricetin with hydroxypropyl-β-cyclodextrin in human HEP G2 Cells. J. Med. Plants Res. 2011, 5:114-118.
46. Zou M., Lu N., Hu C., Liu W., Sun Y., Wang X., You Q., Gu C., Xi T., Guo Q. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: Implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell. Signal. 2012, 24:1722-1732.